Does RUXOLITINIB Cause Dehydration? 487 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 487 reports of Dehydration have been filed in association with RUXOLITINIB (OPZELURA). This represents 0.7% of all adverse event reports for RUXOLITINIB.
487
Reports of Dehydration with RUXOLITINIB
0.7%
of all RUXOLITINIB reports
58
Deaths
355
Hospitalizations
How Dangerous Is Dehydration From RUXOLITINIB?
Of the 487 reports, 58 (11.9%) resulted in death, 355 (72.9%) required hospitalization, and 35 (7.2%) were considered life-threatening.
Is Dehydration Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RUXOLITINIB. However, 487 reports have been filed with the FAERS database.
What Other Side Effects Does RUXOLITINIB Cause?
Off label use (12,492)
Death (6,561)
Fatigue (5,663)
Anaemia (3,593)
Haemoglobin decreased (3,297)
Platelet count decreased (3,028)
Diarrhoea (2,531)
Asthenia (2,529)
Dizziness (2,398)
Pneumonia (2,343)
What Other Drugs Cause Dehydration?
LENALIDOMIDE (3,469)
ADALIMUMAB (3,233)
CALCIUM\DEXTROSE\MAGNESIUM\SODIUM\SODIUM (3,168)
FUROSEMIDE (2,195)
SEMAGLUTIDE (1,816)
METFORMIN (1,754)
CAPECITABINE (1,599)
LENVATINIB (1,526)
TIRZEPATIDE (1,187)
SACUBITRIL\VALSARTAN (1,171)
Which RUXOLITINIB Alternatives Have Lower Dehydration Risk?
RUXOLITINIB vs SABRIL
RUXOLITINIB vs SACCHAROMYCES CEREVISIAE
RUXOLITINIB vs SACITUZUMAB GOVITECAN
RUXOLITINIB vs SACITUZUMAB GOVITECAN-HZIY
RUXOLITINIB vs SACROSIDASE